121 related articles for article (PubMed ID: 30972876)
1. Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
Yang W; Liu H; Duan B; Xu X; Carmody D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Chen X; Wei Q
Cancer Sci; 2019 Jun; 110(6):2022-2032. PubMed ID: 30972876
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.
Xu X; Qian D; Liu H; Cruz D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Wei Q
Mol Carcinog; 2019 Aug; 58(8):1338-1348. PubMed ID: 30997723
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk.
Duan B; Hu J; Liu H; Wang Y; Li H; Liu S; Xie J; Owzar K; Abbruzzese J; Hurwitz H; Gao H; Wei Q
Int J Cancer; 2018 Apr; 142(7):1322-1331. PubMed ID: 29168174
[TBL] [Abstract][Full Text] [Related]
4. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
6. Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.
Zhao L; Liu H; Luo S; Moorman PG; Walsh KM; Li W; Wei Q
Cancer Med; 2020 Dec; 9(24):9620-9631. PubMed ID: 33200553
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.
Shin JH; Lee KM; Shin J; Kang KD; Nho CW; Cho YS
Genes Genomics; 2019 May; 41(5):537-545. PubMed ID: 30767168
[TBL] [Abstract][Full Text] [Related]
8. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
9. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets.
Chen J; Wu X; Huang Y; Chen W; Brand RE; Killary AM; Sen S; Frazier ML
Oncotarget; 2016 Aug; 7(35):56480-56490. PubMed ID: 27486767
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.
Ge J; Liu H; Qian D; Wang X; Moorman PG; Luo S; Hwang S; Wei Q
Int J Cancer; 2019 Sep; 145(5):1270-1279. PubMed ID: 31026346
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
Guo X; Lin W; Bao J; Cai Q; Pan X; Bai M; Yuan Y; Shi J; Sun Y; Han MR; Wang J; Liu Q; Wen W; Li B; Long J; Chen J; Zheng W
Am J Hum Genet; 2018 May; 102(5):890-903. PubMed ID: 29727689
[TBL] [Abstract][Full Text] [Related]
12. Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.
Feng Y; Wang Y; Liu H; Liu Z; Mills C; Owzar K; Xie J; Han Y; Qian DC; Hung Rj RJ; Brhane Y; McLaughlin J; Brennan P; Bickeböller H; Rosenberger A; Houlston RS; Caporaso N; Landi MT; Brüske I; Risch A; Ye Y; Wu X; Christiani DC; Amos CI; Wei Q
Mol Carcinog; 2018 Feb; 57(2):216-224. PubMed ID: 29071797
[TBL] [Abstract][Full Text] [Related]
13. Functional Annotation of Genetic Loci Associated With Sepsis Prioritizes Immune and Endothelial Cell Pathways.
Le KTT; Matzaraki V; Netea MG; Wijmenga C; Moser J; Kumar V
Front Immunol; 2019; 10():1949. PubMed ID: 31475010
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of expression quantitative trait loci identified potential lung cancer susceptibility variants among Asian populations.
Fan J; Zhu M; Wang Y; Li Z; Zhang J; Wang L; Sun Q; Dai J; Jin G; Hu Z; Shen H; Ma H
Carcinogenesis; 2019 Apr; 40(2):263-268. PubMed ID: 30689816
[TBL] [Abstract][Full Text] [Related]
15. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Hartikainen JM; Tengström M; Kosma VM; Kinnula VL; Mannermaa A; Soini Y
Cancer Res; 2012 Nov; 72(21):5537-46. PubMed ID: 22964583
[TBL] [Abstract][Full Text] [Related]
17. Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.
Wang Y; Wu W; Zhu M; Wang C; Shen W; Cheng Y; Geng L; Li Z; Zhang J; Dai J; Ma H; Chen L; Hu Z; Jin G; Shen H
Int J Cancer; 2018 Apr; 142(8):1602-1610. PubMed ID: 29193083
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
19. Associations of novel variants in
Zhao LL; Liu HL; Luo S; Walsh KM; Li W; Wei Q
Am J Cancer Res; 2020; 10(7):2128-2144. PubMed ID: 32775006
[TBL] [Abstract][Full Text] [Related]
20. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.
Zhang M; Wang Z; Obazee O; Jia J; Childs EJ; Hoskins J; Figlioli G; Mocci E; Collins I; Chung CC; Hautman C; Arslan AA; Beane-Freeman L; Bracci PM; Buring J; Duell EJ; Gallinger S; Giles GG; Goodman GE; Goodman PJ; Kamineni A; Kolonel LN; Kulke MH; Malats N; Olson SH; Sesso HD; Visvanathan K; White E; Zheng W; Abnet CC; Albanes D; Andreotti G; Brais L; Bueno-de-Mesquita HB; Basso D; Berndt SI; Boutron-Ruault MC; Bijlsma MF; Brenner H; Burdette L; Campa D; Caporaso NE; Capurso G; Cavestro GM; Cotterchio M; Costello E; Elena J; Boggi U; Gaziano JM; Gazouli M; Giovannucci EL; Goggins M; Gross M; Haiman CA; Hassan M; Helzlsouer KJ; Hu N; Hunter DJ; Iskierka-Jazdzewska E; Jenab M; Kaaks R; Key TJ; Khaw KT; Klein EA; Kogevinas M; Krogh V; Kupcinskas J; Kurtz RC; Landi MT; Landi S; Le Marchand L; Mambrini A; Mannisto S; Milne RL; Neale RE; Oberg AL; Panico S; Patel AV; Peeters PH; Peters U; Pezzilli R; Porta M; Purdue M; Quiros JR; Riboli E; Rothman N; Scarpa A; Scelo G; Shu XO; Silverman DT; Soucek P; Strobel O; Sund M; Małecka-Panas E; Taylor PR; Tavano F; Travis RC; Thornquist M; Tjønneland A; Tobias GS; Trichopoulos D; Vashist Y; Vodicka P; Wactawski-Wende J; Wentzensen N; Yu H; Yu K; Zeleniuch-Jacquotte A; Kooperberg C; Risch HA; Jacobs EJ; Li D; Fuchs C; Hoover R; Hartge P; Chanock SJ; Petersen GM; Stolzenberg-Solomon RS; Wolpin BM; Kraft P; Klein AP; Canzian F; Amundadottir LT
Oncotarget; 2016 Oct; 7(41):66328-66343. PubMed ID: 27579533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
